| Dr Stephanie Walker, PHARMD | |
|
975 Kirman Ave, Reno, NV 89502-0993 | |
| (775) 786-7200 | |
| Not Available |
| Full Name | Dr Stephanie Walker |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 975 Kirman Ave, Reno, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043671266 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 18586 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephanie Walker, PHARMD 975 Kirman Ave, Reno, NV 89502-0993 Ph: (775) 786-7200 | Dr Stephanie Walker, PHARMD 975 Kirman Ave, Reno, NV 89502-0993 Ph: (775) 786-7200 |
News Archive
The U.S. Food and Drug Administration currently recommends regular follow-up magnetic resonance imaging (MRI) scans for women with silicone breast implants. But a new review shows significant flaws in the evidence supporting this recommendation, reports the March issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Targeted therapies are a growing and groundbreaking field in cancer care in which drugs or other substances are designed to interfere with genes or molecules that control the growth and survival of cancer cells. Now, scientists at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have identified a novel interaction between a microRNA and a gene that could lead to new therapies for the most common and deadly form of brain tumor, malignant glioma.
The immune system is fickle, and easily influenced by more than just viruses and bacteria. It can be swayed by the seemingly unexpected, such as by what we eat, for example, and affected by surprising sources.
Structural biologists at Cold Spring Harbor Laboratory (CSHL) have obtained a precise molecular map of the binding site for an allosteric inhibitor in a subtype of the NMDA (N-methyl-D-aspartate) receptor, which is commonly expressed in brain cells.
A new study presented at the 2019 ACR/ARP Annual Meeting says that all rheumatoid arthritis (RA) patients, irrespective of their age, benefit to a similar extent from the use of biologic drugs in their treatment. The study measured improvement in disease parameters 48 weeks after the beginning of therapy to establish this conclusion.
› Verified 2 days ago
Leisa Ann Sitroneto, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2200 Harvard Way, Reno, NV 89502 Phone: 775-689-2211 Fax: 775-689-2438 | |
Lynn R Sorensen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1901 Silverada Blvd, Reno, NV 89512 Phone: 775-358-4337 Fax: 775-355-9609 | |
Thanhxuan Thi Vo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 18144 Wedge Pkwy, Reno, NV 89511 Phone: 775-850-8920 | |
John Roger White, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Locust St, Reno, NV 89502 Phone: 775-328-1840 Fax: 775-328-1838 | |
Brandon Battis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1075 N Hills Blvd, Reno, NV 89506 Phone: 775-762-8021 | |
Mr. Patrick Kim, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1055 South Wells, Reno, NV 89502 Phone: 775-336-3035 Fax: 775-348-3879 | |
Jason Mccomb, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9738 S Virginia St, Ste F, Reno, NV 89511 Phone: 775-853-3502 Fax: 775-236-5771 |